Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.
Saved in:
| Title: | Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice. |
|---|---|
| Authors: | Saito N; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.; Department of Hematology, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan., Yamauchi T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Kawano N; Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan., Ono R; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Yoshida S; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan., Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Kamimura T; Division of Hematology, Harasanshin Hospital, Fukuoka, Japan., Shultz LD; The Jackson Laboratory, Bar Harbor, ME, USA., Saito Y; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Takenaka K; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan., Shimoda K; Division of Hematology, Diabetes, and Endocrinology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Harada M; Karatsu Higashimatsuura Medical Center, Karatsu, Japan., Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. akashi@med.kyushu-u.ac.jp., Ishikawa F; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. fumihiko.ishikawa@riken.jp. |
| Source: | International journal of hematology [Int J Hematol] 2022 Feb; Vol. 115 (2), pp. 198-207. Date of Electronic Publication: 2021 Nov 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34773575 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Saito+N%22">Saito N</searchLink>; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.; Department of Hematology, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuo-ku, Fukuoka, 810-0001, Japan.<br /><searchLink fieldCode="AU" term="%22Yamauchi+T%22">Yamauchi T</searchLink>; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Kawano+N%22">Kawano N</searchLink>; Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.<br /><searchLink fieldCode="AU" term="%22Ono+R%22">Ono R</searchLink>; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+S%22">Yoshida S</searchLink>; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Miyamoto+T%22">Miyamoto T</searchLink>; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Kamimura+T%22">Kamimura T</searchLink>; Division of Hematology, Harasanshin Hospital, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Shultz+LD%22">Shultz LD</searchLink>; The Jackson Laboratory, Bar Harbor, ME, USA.<br /><searchLink fieldCode="AU" term="%22Saito+Y%22">Saito Y</searchLink>; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Takenaka+K%22">Takenaka K</searchLink>; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.<br /><searchLink fieldCode="AU" term="%22Shimoda+K%22">Shimoda K</searchLink>; Division of Hematology, Diabetes, and Endocrinology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.<br /><searchLink fieldCode="AU" term="%22Harada+M%22">Harada M</searchLink>; Karatsu Higashimatsuura Medical Center, Karatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Akashi+K%22">Akashi K</searchLink>; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. akashi@med.kyushu-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Ishikawa+F%22">Ishikawa F</searchLink>; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. fumihiko.ishikawa@riken.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2022 Feb; Vol. 115 (2), pp. 198-207. <i>Date of Electronic Publication: </i>2021 Nov 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34773575 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12185-021-03239-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 198 Titles: – TitleFull: Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saito N – PersonEntity: Name: NameFull: Yamauchi T – PersonEntity: Name: NameFull: Kawano N – PersonEntity: Name: NameFull: Ono R – PersonEntity: Name: NameFull: Yoshida S – PersonEntity: Name: NameFull: Miyamoto T – PersonEntity: Name: NameFull: Kamimura T – PersonEntity: Name: NameFull: Shultz LD – PersonEntity: Name: NameFull: Saito Y – PersonEntity: Name: NameFull: Takenaka K – PersonEntity: Name: NameFull: Shimoda K – PersonEntity: Name: NameFull: Harada M – PersonEntity: Name: NameFull: Akashi K – PersonEntity: Name: NameFull: Ishikawa F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2022 Feb Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1865-3774 Numbering: – Type: volume Value: 115 – Type: issue Value: 2 Titles: – TitleFull: International journal of hematology Type: main |
| ResultId | 1 |